Ancora Heart Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
Series I
- Latest Deal Amount
-
$80M
- Investors
-
11
Ancora Heart General Information
Description
Developer of a percutaneous ventricular restoration system designed to treat heart failure including extreme fatigue, difficulty breathing or memory loss. The company's system targets the dysfunction of the left ventricle, reduces its size and supports and strengthens the heart wall, enabling people with heart failure to live comfortably.
Contact Information
Website
www.ancoraheart.comCorporate Office
- 4001 Burton Drive
- Santa Clara, CA 95054
- United States
Corporate Office
- 4001 Burton Drive
- Santa Clara, CA 95054
- United States
Ancora Heart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series I) | 06-Jul-2021 | $80M | Completed | Generating Revenue | ||
| 8. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series H) | 11-Jan-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series G) | 21-Dec-2018 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 01-Jan-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 28-Apr-2010 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 05-Feb-2008 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 13-Mar-2006 | $14.1M | $14.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 09-Jul-2003 | $462K | $462K | Completed | Startup |
Ancora Heart Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series I | ||||||||
| Series H | ||||||||
| Series G | 10,766,876 | $0.001000 | $1.76 | $1.76 | 1x | $1.76 | 13.9% | |
| Series F | 18,646,522 | $0.001000 | $1 | $1 | 1x | $1 | 24.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ancora Heart Comparisons
Industry
Financing
Details
Ancora Heart Competitors (2)
One of Ancora Heart’s 2 competitors is BioVentrix, a Venture Capital-Backed company based in San Ramon, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioVentrix | Venture Capital-Backed | San Ramon, CA | ||||
| Foldax | Venture Capital-Backed | Salt Lake City, UT |
Ancora Heart Patents
Ancora Heart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240390145-A1 | Systems and methods for deploying devices into cardiac tissue | Pending | 24-Apr-2023 | ||
| AU-2021208554-A1 | Devices and methods for positioning a guidewire | Pending | 15-Jan-2020 | ||
| US-20210213257-A1 | Devices and methods for positioning a guidewire | Pending | 15-Jan-2020 | ||
| CA-3167029-A1 | Devices and methods for positioning a guidewire | Pending | 15-Jan-2020 | ||
| EP-4090407-A1 | Devices and methods for positioning a guidewire | Pending | 15-Jan-2020 | A61M25/09041 |
Ancora Heart Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ancora Heart Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| RTW Investments | Hedge Fund | Minority | ||
| Sands Capital | Growth/Expansion | Minority | ||
| Sio Capital Management | Hedge Fund | Minority | ||
| Savitr Capital | Venture Capital | Minority | ||
| Ascent Biomedical Ventures | Venture Capital | Minority |
Ancora Heart FAQs
-
When was Ancora Heart founded?
Ancora Heart was founded in 2001.
-
Where is Ancora Heart headquartered?
Ancora Heart is headquartered in Santa Clara, CA.
-
What is the size of Ancora Heart?
Ancora Heart has 52 total employees.
-
What industry is Ancora Heart in?
Ancora Heart’s primary industry is Therapeutic Devices.
-
Is Ancora Heart a private or public company?
Ancora Heart is a Private company.
-
What is the current valuation of Ancora Heart?
The current valuation of Ancora Heart is .
-
What is Ancora Heart’s current revenue?
The current revenue for Ancora Heart is .
-
How much funding has Ancora Heart raised over time?
Ancora Heart has raised $236M.
-
Who are Ancora Heart’s investors?
RTW Investments, Sands Capital, Sio Capital Management, Savitr Capital, and Ascent Biomedical Ventures are 5 of 11 investors who have invested in Ancora Heart.
-
Who are Ancora Heart’s competitors?
BioVentrix and Foldax are competitors of Ancora Heart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
